Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHRQ announces ARRA grant funding

This article was originally published in The Gray Sheet

Executive Summary

Agency for Healthcare Research and Quality announces Sept. 30 it has awarded $473 million in grants and contracts that support patient-centered outcomes research - formerly known as comparative effectiveness research - under the American Recovery and Reinvestment Act of 2009 (1"The Gray Sheet" Aug. 10, 2009). Of the total, $300 million covers allocation of AHRQ funding, and $173 was administered by AHRQ on behalf of the secretary of the Department of Health and Human Services. The research addresses not only comparisons of different medical treatments, but also of different health care delivery systems and methods

You may also be interested in...



AHRQ, NIH Report To Congress On Comparative Effectiveness Spending Plans

Two Health and Human Services agencies will allocate about $250 million this year in comparative effectiveness research funds from the federal stimulus package; the remainder of the $1.1 billion comparative effectiveness money will be put to use in 2010

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel